Dr. Kavita Yang Sarin, MD

Dr. Sarin practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Sarin's NPI, 1851565956, was assigned on April 18, 2008. Dr. Sarin graduated from Stanford University School Of Medicine in 2008. Dr. Sarin holds California license A109187.

Dr. Sarin's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Sarin's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Sarin to 1 more hospital, named with a free account. Dr. Sarin's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sarin practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Sarin's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Sarin is board certified in dermatology by the American Board of Dermatology. Dr. Sarin is licensed in California.

Dmand AI lists acne, benign or precancerous skin growths, contact dermatitis, hives, itchy rashes, joint cyst, psoriasis and rash among the conditions Dr. Sarin treats.

CMS data shows 936 Medicare services from Dr. Sarin across 9 procedure codes in 2024, for 210 Medicare patients. Medicare paid $47,667 for them. Every service was in an office.

CMS counts 210 Medicare patients who saw Dr. Sarin in 2024. The largest group is 65 to 74, with 85 patients. 67% of them have high cholesterol, and 58% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.07, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Sarin's median patient age at 51, with 62% women.

In 2024, Dr. Sarin wrote 322 Medicare Part D claims for 90 patients. 90% of them were for generic drugs. CMS names the drug for 165 of them, across 10 drugs with 11 or more claims each, at $3,493 in total drug cost. In 2023, CMS named 97 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Sarin for performance year 2024, reported as part of a group. Dr. Sarin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sarin as offering telehealth. CMS counts 303 procedures of removal of skin lesions by Dr. Sarin, more than 82% of the clinicians it reports for that procedure.

Dmand AI links 130 papers to Dr. Sarin, published from 2007 to 2025. 2019 was the busiest year, with 12. The most frequent topics are Skin Neoplasms, Carcinoma, Basal Cell and Genetic Predisposition to Disease. Dr. Sarin has published most often in J Am Acad Dermatol. Dr. Sarin's most frequent co-authors are Anthony Eugene Oro, MD, Kerri Elyse Rieger, MD, PhD and Anne Lynn Su Chang, MD.

Dmand AI links Dr. Sarin to 3 clinical trials, 2 of them phase 2 studies. Conditions studied include Carcinoma, Basal Cell, Dermatitis, Atopic and Hidradenitis Suppurativa. Stanford University sponsors the most, 2.

CMS Open Payments shows 30 general payments to Dr. Sarin from 10 drug and device companies from 2016 to 2025. Grants make up the largest share, 51% of the total. Genentech, Inc. paid the most, $36,932.

Dmand AI lists 9 awards for Dr. Sarin, most recently Medical Career Development Award in 2014.

Dr. Sarin graduated from Stanford University School Of Medicine in 2008.

Dr. Sarin is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.